Two Bay Area primary care physicians, Annie Chern, M.D. and Mitesh Popat, M.D., have joined our medical advisory board of clinical leaders in otolaryngology and allergy/immunology.
Dr. Chern and Dr. Popat will provide their expert opinions from a primary care perspective, on our clinical activities and identify key opportunities for physician education and engagement.
According to our research, 70% of patients with sinus symptoms see their primary care physicians for treatment, so this underscores the importance of raising awareness for ClearUP® Sinus Pain Relief within this group of medical practitioners.
Dr. Annie Chern is on the faculty at Stanford Health Care Family Medicine Residency Program. She previously served on the executive committee of the Department of Pediatrics at O’Connor Hospital in San Jose and currently serves as their Department Chair of Family Medicine. Dr. Chern is a graduate of Stanford University School of Medicine and completed her residency in Family Medicine at Stanford Family Medicine Program.
“As a teaching faculty member of Stanford Health Care, I am always interested in innovations that can enhance patient care and treatment options,” said Dr. Chern. “Tivic Health’s first product ClearUP relieves symptoms of sinus inflammation like pain and congestion without the side effect burden that comes with many over-the-counter drugs. I believe ClearUP has an important place in the primary care toolbox, and I look forward to helping Tivic Health further integrate ClearUP into clinical practice.”
Dr. Mitesh Popat is Chief Executive Officer of Marin Community Clinics and Chief Clinical Officer of Sprinter Health. He serves on numerous boards, including for Partnership Health Plan of California and previously for the American Cancer Society. In addition, he has spearheaded innovations in care delivery, with a focus on operational execution and financial viability. Dr. Popat is a board-certified family physician with a Doctor of Medicine and has a Master of Public Health from Tufts University in Boston.
“As I have learned about the growing field of digital health and the many emerging innovations, such as bioelectronic medicine, I am compelled by the potential impact that companies like Tivic Health can have in healthcare as they continue to develop novel treatments,” said Dr. Popat. “In fact, I am a sufferer of sinus and nasal inflammation and have found great benefit from using the ClearUP device regularly.”
We welcome Dr. Chern and Dr. Popat to the Tivic Health team!
 OnePoll randomized survey of 2,000 U.S. allergy sufferers, on behalf of Tivic Health, April 2022